Effect of cholecalciferol on local arterial stiffness and endothelial dysfunction in children with chronic kidney disease

AYTAÇ M. B., Deveci M., BEK K., Kayabey O., Ekinci Z.

PEDIATRIC NEPHROLOGY, cilt.31, sa.2, ss.267-277, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1007/s00467-015-3220-5
  • Dergi Adı: PEDIATRIC NEPHROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.267-277
  • Anahtar Kelimeler: Chronic kidney disease, 25-hydroxyvitamin D3, Children, Flow-mediated dilatation, Arterial stiffness, VITAMIN-D DEFICIENCY, STAGE RENAL-DISEASE, LEFT-VENTRICULAR HYPERTROPHY, CARDIOVASCULAR MORTALITY, HEMODIALYSIS-PATIENTS, MINERAL METABOLISM, HYPERHOMOCYSTEINEMIA, DIALYSIS, IMPACT, ADULTS
  • Kocaeli Üniversitesi Adresli: Evet

Özet

As cardiovascular factors are the leading cause of mortality in chronic kidney disease (CKD) and as vitamin D deficiency is prevalent in this population, we aimed to examine the effect of oral cholecalciferol on cardiac parameters and biomarkers for endothelial cell activation in children with CKD.